Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vbi Vaccines Inc CS
(NQ:
VBIV
)
0.5749
-0.0245 (-4.09%)
Streaming Delayed Price
Updated: 3:06 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vbi Vaccines Inc CS
< Previous
1
2
3
4
5
6
7
Next >
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
On Tuesday, 74 companies achieved new lows for the year.
Via
Benzinga
VBI Vaccines Earnings Perspective: Return On Capital Employed
March 15, 2023
Via
Benzinga
VBI Vaccines Reports Full Year 2022 Financial Results
March 13, 2023
From
VBI Vaccines Inc.
Via
Business Wire
Looking Into VBI Vaccines's Return On Capital Employed
December 20, 2022
Via
Benzinga
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
October 12, 2022
Via
Benzinga
VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat
February 23, 2023
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces Presentation of Interim Phase 2 Data Evaluating Combination of VBI-2601 (BRII-179) and BRII-835 for the Treatment of Chronic Hepatitis B
February 15, 2023
From
VBI Vaccines Inc.
Via
Business Wire
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 18, 2023
Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 05, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers for Thursday that traders need to know about!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
December 28, 2022
On Wednesday, 258 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 22, 2022
Thursday's session saw 329 companies set new 52-week lows.
Via
Benzinga
VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults
December 08, 2022
From
VBI Vaccines Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
December 07, 2022
Wednesday saw 219 companies set new 52-week lows.
Via
Benzinga
CEPI Boosts ‘Coronavirus X’ Vaccine Search With Expanded VBI Vaccines Deal
December 06, 2022
From
VBI Vaccines Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
November 22, 2022
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines to Participate in Upcoming Investor Conferences
November 14, 2022
From
VBI Vaccines Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
November 11, 2022
Upgrades
Via
Benzinga
VBI Vaccines Announces Presentation of Data from Ongoing Phase 2a Study of VBI-1901 at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
November 11, 2022
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 10, 2022
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines to Participate in H.C. Wainwright 3rd Annual Hepatitis B Virus (HBV) Conference
October 17, 2022
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
October 12, 2022
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
October 12, 2022
From
Agenus Inc.
Via
GlobeNewswire
VBI Vaccines Announces Initiation of Phase 1 Study of Multivalent Coronavirus Vaccine Candidate, VBI-2901
September 29, 2022
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Announces Presentation of Physician-Initiated Compassionate Use Data of its 3-Antigen Hepatitis B Vaccine at the 2022 International HBV Meeting
September 21, 2022
From
VBI Vaccines Inc.
Via
Business Wire
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
September 15, 2022
From
VBI Vaccines Inc.
Via
Business Wire
Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®
September 08, 2022
From
VBI Vaccines Inc.
Via
Business Wire
Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session
August 29, 2022
Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ.
Via
Benzinga
Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket
August 29, 2022
Gainers NewAge, Inc. (NASDAQ: NBEV) shares rose 19.7% to $0.2432 in pre-market trading. NewAge recently received Nasdaq notice on late filing of its form 10-Q.
Via
Benzinga
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
August 19, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.